Medical News

RSS

IntelGenx and LTS announce strategic alliance

IntelGenx Corp. ("IntelGenx") today announced a strategic alliance with LTS Lohmann Therapie-Systeme AG ("LTS") for the exclusive manufacturing of products developed by IntelGenx using its VersaFilm drug delivery technology.

25 Jan 2010

BioScrip signs definitive agreement to acquire Critical Homecare Solutions

BioScrip, Inc. today announced it has signed a definitive agreement to acquire Critical Homecare Solutions (“CHS”), a leading provider of home infusion and home health agency services to patients suffering from chronic and acute medical conditions.

25 Jan 2010

Formulations market: Network to place the Yorkshire and Humber region at the forefront launched

A collaborative network that aims to put the Yorkshire and Humber region at the forefront of the development of product formulations to improve everyday products is being launched in Leeds.

25 Jan 2010

NPD Group names yogurt as food trend of the decade

Americans are eating more yogurt than ever before, and Dairy Council of California advises that consumers can benefit from even more culture.

25 Jan 2010

European study results on consumer use of nutrition information on food labels available online

Results from a European study on consumer use of nutrition information on food labels and their understanding of front-of-pack nutrition information, are now available ahead of print on the website of the Journal of Public Health.

25 Jan 2010

Institute of Medicine urges healthcare providers to take steps to battle hepatitis B and C

The Institute of Medicine, a branch of the US National Academy of Sciences, is urging healthcare providers to take steps to battle liver-damaging hepatitis B and C, which are often overlooked viruses.

25 Jan 2010

Ministerial Preparatory Conference on Haiti: Canadian Red Cross announces participation

Canadian Red Cross Secretary General and CEO Conrad Sauvé is pleased to represent the International Federation of Red Cross Red Crescent Societies (IFRC) at the Ministerial Preparatory Conference on Haiti in Montreal on Jan. 25, 2010.

25 Jan 2010

Blood donors extend their life-saving gifts to help Haiti's earthquake victims

New York Blood Center (NYBC), serving New York City, Long Island, the Hudson Valley, and New Jersey, will donate one dollar to the U.S. Fund for UNICEF for each blood donation made from January 25-31.

25 Jan 2010

NTNU: 40% of two-year-olds report allergy-related disorders

Allergies and asthma are a continuing health problem in most developed countries, but just how do these ailments develop over the course of a childhood? In a population-based study designed to help answer this question, researchers at the Norwegian University of Science and Technology (NTNU) found that 40 per cent - or two of five -- of nearly 5,000 two-year-olds had at least one reported allergy-related disorder. The most common symptom was wheezing, which was reported in 26 per cent of all children in the study, says Ingeborg Smidesang, a PhD candidate in the university's Faculty of Medicine, and the primary author of the study.

25 Jan 2010

New online resource to help people with Oral Mucositis launched

From today, a new resource is available to help people with Oral Mucositis: http://www.mouthsmadegood.com. Oral Mucositis (OM) is a side effect of cancer therapy and is characterised by a red, swollen and ulcerated mouth and tongue.

25 Jan 2010

Low-cost ventilators for healthcare emergencies

A group of UK anaesthetists have designed and tested three prototype low-cost ventilators that could provide vital support during major healthcare emergencies involving large numbers of patients or casualties. The devices, detailed in a paper published online by Anaesthesia, could also be used where resources are limited, such as in developing countries, remote locations or by the military.

25 Jan 2010

Proposal for NHI to be the most significant development in South Africa's healthcare sector in 2010

The proposal for a National Health Insurance (NHI) was without doubt the most significant development in South Africa's healthcare sector in 2010. The aim of the NHI is to create universal healthcare coverage for all the country's citizens.

25 Jan 2010

Research paves way for future vaccine against gastric adenocarcinoma

Despite a strong response from our immune defence, the body is unable to rid itself of the bacterium Helicobacter pylori. One reason for this is that this bacterium encourages elements of the immune response to remain in tissue, activating the wrong immune cells. Research results that pave the way for a future vaccine are now being published by the Sahlgrenska Academy at the University of Gothenburg, Sweden.

25 Jan 2010

Self-treatment for back pain: Sensory motor learning

Many people with back pain do not know what is causing it and they do not receive effective treatment, but learning to move in a more integrated way makes a big difference, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

25 Jan 2010

IntegraGen now offers Fluidigm's IFC technology to French researchers

Fluidigm, the inventor of integrated fluidic circuits (IFCs), has joined with IntegraGen SA, one of France’s leading providers of genetic research testing services, to bring IFC technology to French researchers. IntegraGen will offer premium class services to its customers using the Fluidigm BioMark™ System for Genetic Analysis and the Access Array™ sample preparation system for next-generation sequencing. IntegraGen’s lab will also be a demonstration site for researchers investigating Fluidigm’s technology.

25 Jan 2010

Halozyme Therapeutics and BioAtla sign research collaboration agreement

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.

25 Jan 2010

Biogen Idec and Swedish Orphan Biovitrum commence dosing in rFIXFc Phase I/IIa trial for hemophilia B

Biogen Idec and Swedish Orphan Biovitrum today announced that the first patient was dosed in a registrational, open-label, multicenter trial designed to evaluate the safety, pharmacokinetics and efficacy of the companies’ long-acting, recombinant Factor IX Fc fusion protein (rFIXFc) in hemophilia B patients.

25 Jan 2010

Elan Drug Technologies issues statement on FDA approval of AMPYRA

Elan Drug Technologies, a business unit of Elan Corporation, plc (NYSE: ELN) today issued the following statement regarding the U.S. Food and Drug Administration (FDA) approval of AMPYRA™ (dalfampridine) as a treatment to improve walking in patients with multiple sclerosis (MS).

25 Jan 2010

AMT reaches another milestone in the official marketing authorisation process for Glybera

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, has reached another important milestone in the official marketing authorisation process for its lead product Glybera(R), AMT's proprietary product for lipoprotein lipase deficiency (LPLD).

25 Jan 2010

Reproductive coercion and partner violence increase risk of unintended pregnancy

Young women and teenage girls often face efforts by male partners to sabotage birth control or coerce pregnancy - including damaging condoms and destroying contraceptives - and these efforts, defined as "reproductive coercion," frequently are associated with physical or sexual violence, a study by a team of researchers led by UC Davis has found.

25 Jan 2010

Medical News

IntelGenx and LTS announce strategic alliance

BioScrip signs definitive agreement to acquire Critical Homecare Solutions

Formulations market: Network to place the Yorkshire and Humber region at the forefront launched

NPD Group names yogurt as food trend of the decade

European study results on consumer use of nutrition information on food labels available online

Institute of Medicine urges healthcare providers to take steps to battle hepatitis B and C

Ministerial Preparatory Conference on Haiti: Canadian Red Cross announces participation

Blood donors extend their life-saving gifts to help Haiti's earthquake victims

NTNU: 40% of two-year-olds report allergy-related disorders

New online resource to help people with Oral Mucositis launched

Low-cost ventilators for healthcare emergencies

Proposal for NHI to be the most significant development in South Africa's healthcare sector in 2010

Research paves way for future vaccine against gastric adenocarcinoma

Self-treatment for back pain: Sensory motor learning

IntegraGen now offers Fluidigm's IFC technology to French researchers

Halozyme Therapeutics and BioAtla sign research collaboration agreement

Biogen Idec and Swedish Orphan Biovitrum commence dosing in rFIXFc Phase I/IIa trial for hemophilia B

Elan Drug Technologies issues statement on FDA approval of AMPYRA

AMT reaches another milestone in the official marketing authorisation process for Glybera

Reproductive coercion and partner violence increase risk of unintended pregnancy

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News